2019年8月24日雅思写作真题回忆
2019年8月24日雅思写作真题回忆
话题分类
社会文化类
题型
双边讨论型
题目
Some people say that drug companies have the responsibility to spend money on researching medicine to help the poorer countries，others think the main responsibility of drug companies is making money. Discuss both sides and give your opinion.
解题思路
题目解读：有人认为药品公司有责任花钱研究药品去帮助贫困国家，而其他人认为主要责任应该是挣钱。讨论双方观点并给出你的意见。
思路：
正方观点
1. 贫穷国家缺医少药需要帮助
2. 全球化,疾病可以蔓延到世界各个角落，帮助他国就是帮自己
3.国家之间应该相互帮助，传播互助的价值观，提升企业形象
→医药公司有责任帮助
反方观点
1. 经济大环境不好，维持本身的生存有压力
2. 公司需要足够的盈利保证持续性发展，提供足够的就业机会
3. 公司开发不同药品很难，也需要足够的经济实力作为基础
→ 主要任务是赚钱
参考范文
From the perspective of some people, drug companies have the obligation to lend a helping hand to countries in poverty by spending money on developing medicine for them. Others, however, hold the view that it is their principal duty to earn money so as to make sure their ability of sustainable development. Personally, I find the latter one more convincing.
Those who support the idea of aiding countries in need do have their own justifications. First of all, people in those countries are commonly faced with the problem of lacking trained doctors and medicine，the result of which is considered to have greatly affected local residents’ health and apparently there is a considerable amount of influence on the country on a whole. The Republic of Botswana , a remote malaria-ridden area in Africa , for instance, has a fatality rate of 66% among all age groups infected by malaria, including 71% for aged below 5. It still draws a great deal of attention around the globe for its suffering. Furthermore, what is now happening there might as well put nearly half the world's population, about 3.2 billion people, at risk from the disease, according to WHO. In other words, a wider range of population can be inflicted if nothing is done to cope with it. Besides, it’s a great chance to promote the company’s positive image as well as its reputation. As it’s widely acknowledged that these underdeveloped countries could become robust emerging markets, building a socially responsible image not only boosts these companies’ brand visibility but also helps them tap into markets with enormous potential. Therefore, it is imperative for drug companies to provide those vulnerable countries with medical treatment and other humanitarian aids.
Nevertheless, it is understandable why other people are against the previous theory. While it is beneficial to actively tackling health issues in other countries, never should one forget what’s the key role of an enterprise -- making profit. Undoubtedly, only in that way can businesses, no matter how big, get a chance to survive, let alone further thriving, which is especially true in such a sluggish global economic environment. Also, an enormous sum of fund is needed to search for new drugs, considering the difficulties those companies confront, from hiring well-qualified professionals to constructing state-of-art laboratories, after all, without research and development infrastructures, hardly can any firm innovate and invent new types of vaccine. For instance, research and development expenditures accounts for 30% or even more of its revenue on scientific experiment for a successful medical corporation on average in developed countries. Thus, it is suggested that it would be better to fulfill their basic function before moving along.
In conclusion, while some people have reasons to believe it is the right thing to do to focus on helping poorer nations, I tend to think that drug companies must survive in order to develop and target for researching into new medicine.
